Table 1.
Subject Characteristics, Body Anthropometrics, and Clamp Metabolic Parameters
| Controls, n = 15 | NAFLD, n = 13 | P Value | |
|---|---|---|---|
| Age, y | 50.6 ± 1.7 | 49.7 ± 2.3 | 0.8 |
| Sex, men/women | 8/7 | 9/4 | 0.3 |
| BMI, kg/m2 | 33.4 ± 1.28 | 32.6 ± 1.1 | 0.7 |
| HbA1c, % | 5.67 ± 0.07 | 5.62 ± 0.06 | 0.6 |
| Alcohol intake, drinks/wk | 3.5 ± 1.1 | 2.7 ± 1.1 | 0.7 |
| L/S | 1.22 ± 0.04 | 0.76 ± 0.06 | <0.001 |
| Body fat mass, % | |||
| Men | 34.2 ± 1.3 | 30.7 ± 1.3 | 0.08 |
| Women | 47.2 ± 2.8 | 48.7 ± 0.9 | 0.6 |
| Body fat mass, kg | 36.1 ± 2.4 | 34.1 ± 3.0 | 0.6 |
| IAF area, cm2 | 177.4 (85.3) | 155.0 (111.3) | 0.5 |
| SQF area, cm2 | 384.4 (200.9) | 355.5 (204.1) | 0.2 |
| Adiponectin, μg/mL | |||
| Men | 6.2 ± 1.2 | 7.0 ± 1.4 | 0.7 |
| Women | 13.5 ± 3.3 | 10.4 ± 1.8 | 0.5 |
| Basal EGP, mg/min | 160.4 ± 14.0 | 155.5 ± 12.4 | 0.8 |
| Suppression EGP end low-dose clamp, % | 56.4 ± 4.3 | 50.1 ± 7.1 | 0.5 |
| Fasting NEFAs, mEq/L | 0.43 ± 0.05 | 0.49 ± 0.03 | 0.3 |
| Suppression NEFAs 0–30 min, % | 40.5 ± 6.8 | 40.0 ± 5.9 | 0.9 |
Abbreviation: HbA1c, hemoglobin A1c.